AAPL332.59+10.93 (+3.40%) ▲|ABBV258.25+1.33 (+0.52%) ▲|ABT103.18+2.43 (+2.41%) ▲|ACN146.05+7.31 (+5.27%) ▲|ADBE224.79+12.62 (+5.95%) ▲|AMAT540.83-21.97 (-3.90%) ▼|AMD527.92-11.78 (-2.18%) ▼|AMGN375.80+4.30 (+1.16%) ▲|AMT167.46+2.81 (+1.71%) ▲|AMZN232.44-1.22 (-0.52%) ▼|AVGO381.50-10.97 (-2.80%) ▼|AXP323.60-17.24 (-5.06%) ▼|BA211.39+2.16 (+1.03%) ▲|BAC61.97+0.69 (+1.12%) ▲|BKNG178.48+5.65 (+3.27%) ▲|BLK1,052.74+15.58 (+1.50%) ▲|BMY62.01+0.50 (+0.81%) ▲|BNY159.03-1.08 (-0.67%) ▼|BRK-B492.14+1.29 (+0.26%) ▲|C132.18+0.30 (+0.22%) ▲|CAT888.77-5.77 (-0.65%) ▼|CL90.48+0.40 (+0.44%) ▲|CMCSA22.43+0.51 (+2.30%) ▲|COF202.15+2.19 (+1.10%) ▲|COP120.36+0.16 (+0.13%) ▲|COST932.51+6.45 (+0.70%) ▲|CRM163.30+6.37 (+4.06%) ▲|CSCO113.45+0.69 (+0.61%) ▲|CVS107.35+0.46 (+0.43%) ▲|CVX195.15+0.73 (+0.37%) ▲|DE622.97+12.95 (+2.12%) ▲|DHR190.76-1.75 (-0.91%) ▼|DIS95.47+2.64 (+2.84%) ▲|DUK129.96+0.70 (+0.54%) ▲|EMR148.03+3.13 (+2.16%) ▲|FDX317.67+2.05 (+0.65%) ▲|GD385.74+3.95 (+1.03%) ▲|GE353.87+4.87 (+1.40%) ▲|GEV1,008.63-22.57 (-2.19%) ▼|GILD129.76-1.10 (-0.84%) ▼|GM82.24+1.57 (+1.94%) ▲|GOOG320.16+1.82 (+0.57%) ▲|GOOGL320.52+2.83 (+0.89%) ▲|GS1,065.11-9.61 (-0.89%) ▼|HD331.23+6.52 (+2.01%) ▲|HON241.05-5.22 (-2.12%) ▼|IBM215.63+8.98 (+4.34%) ▲|INTC94.57-5.67 (-5.65%) ▼|INTU293.02+11.49 (+4.08%) ▲|ISRG338.15+6.13 (+1.85%) ▲|JNJ262.81+3.54 (+1.37%) ▲|JPM352.78+2.88 (+0.82%) ▲|KO82.12+0.95 (+1.17%) ▲|LIN512.25+5.93 (+1.17%) ▲|LLY1,192.60+6.73 (+0.57%) ▲|LMT581.87+13.28 (+2.33%) ▲|LOW206.37+4.45 (+2.20%) ▲|LRCX308.15-11.63 (-3.64%) ▼|MA535.59+5.30 (+1.00%) ▲|MCD264.80+2.00 (+0.76%) ▲|MDLZ60.43+0.38 (+0.63%) ▲|MDT83.17+1.16 (+1.41%) ▲|META601.64-4.46 (-0.74%) ▼|MMM170.74+1.15 (+0.68%) ▲|MO73.02+0.94 (+1.30%) ▲|MRK131.06+0.58 (+0.44%) ▲|MS214.83-0.35 (-0.16%) ▼|MSFT384.21+2.63 (+0.69%) ▲|MU921.13-69.08 (-6.98%) ▼|NEE89.17-0.63 (-0.70%) ▼|NFLX70.21+1.32 (+1.91%) ▲|NKE41.82+0.83 (+2.01%) ▲|NOW98.04+6.10 (+6.63%) ▲|NVDA208.57-0.19 (-0.09%) ▼|ORCL116.98-3.07 (-2.55%) ▼|PEP136.67+1.72 (+1.27%) ▲|PFE24.57-0.02 (-0.06%) ▼|PG146.79+0.91 (+0.62%) ▲|PLTR123.90+0.53 (+0.43%) ▲|PM194.43+3.31 (+1.73%) ▲|QCOM167.52-3.59 (-2.10%) ▼|RTX212.90+3.74 (+1.79%) ▲|SBUX103.83+0.62 (+0.60%) ▲|SCHW101.44-0.17 (-0.17%) ▼|SO97.12+0.52 (+0.54%) ▲|SPG228.87+3.67 (+1.63%) ▲|T23.97+1.01 (+4.39%) ▲|TMO562.88-9.44 (-1.65%) ▼|TMUS180.36+9.94 (+5.83%) ▲|TSLA308.00-11.69 (-3.66%) ▼|TXN280.99-4.01 (-1.41%) ▼|UBER69.00+0.09 (+0.13%) ▲|UNH419.92-3.64 (-0.86%) ▼|UNP307.54+3.21 (+1.05%) ▲|UPS114.86+0.76 (+0.67%) ▲|USB63.79+0.46 (+0.73%) ▲|V353.97+2.37 (+0.67%) ▲|VZ45.73+1.91 (+4.35%) ▲|WFC86.45+0.26 (+0.30%) ▲|WMT109.31+0.91 (+0.84%) ▲|XOM156.97+0.08 (+0.05%) ▲|AAPL332.59+10.93 (+3.40%) ▲|ABBV258.25+1.33 (+0.52%) ▲|ABT103.18+2.43 (+2.41%) ▲|ACN146.05+7.31 (+5.27%) ▲|ADBE224.79+12.62 (+5.95%) ▲|AMAT540.83-21.97 (-3.90%) ▼|AMD527.92-11.78 (-2.18%) ▼|AMGN375.80+4.30 (+1.16%) ▲|AMT167.46+2.81 (+1.71%) ▲|AMZN232.44-1.22 (-0.52%) ▼|AVGO381.50-10.97 (-2.80%) ▼|AXP323.60-17.24 (-5.06%) ▼|BA211.39+2.16 (+1.03%) ▲|BAC61.97+0.69 (+1.12%) ▲|BKNG178.48+5.65 (+3.27%) ▲|BLK1,052.74+15.58 (+1.50%) ▲|BMY62.01+0.50 (+0.81%) ▲|BNY159.03-1.08 (-0.67%) ▼|BRK-B492.14+1.29 (+0.26%) ▲|C132.18+0.30 (+0.22%) ▲|CAT888.77-5.77 (-0.65%) ▼|CL90.48+0.40 (+0.44%) ▲|CMCSA22.43+0.51 (+2.30%) ▲|COF202.15+2.19 (+1.10%) ▲|COP120.36+0.16 (+0.13%) ▲|COST932.51+6.45 (+0.70%) ▲|CRM163.30+6.37 (+4.06%) ▲|CSCO113.45+0.69 (+0.61%) ▲|CVS107.35+0.46 (+0.43%) ▲|CVX195.15+0.73 (+0.37%) ▲|DE622.97+12.95 (+2.12%) ▲|DHR190.76-1.75 (-0.91%) ▼|DIS95.47+2.64 (+2.84%) ▲|DUK129.96+0.70 (+0.54%) ▲|EMR148.03+3.13 (+2.16%) ▲|FDX317.67+2.05 (+0.65%) ▲|GD385.74+3.95 (+1.03%) ▲|GE353.87+4.87 (+1.40%) ▲|GEV1,008.63-22.57 (-2.19%) ▼|GILD129.76-1.10 (-0.84%) ▼|GM82.24+1.57 (+1.94%) ▲|GOOG320.16+1.82 (+0.57%) ▲|GOOGL320.52+2.83 (+0.89%) ▲|GS1,065.11-9.61 (-0.89%) ▼|HD331.23+6.52 (+2.01%) ▲|HON241.05-5.22 (-2.12%) ▼|IBM215.63+8.98 (+4.34%) ▲|INTC94.57-5.67 (-5.65%) ▼|INTU293.02+11.49 (+4.08%) ▲|ISRG338.15+6.13 (+1.85%) ▲|JNJ262.81+3.54 (+1.37%) ▲|JPM352.78+2.88 (+0.82%) ▲|KO82.12+0.95 (+1.17%) ▲|LIN512.25+5.93 (+1.17%) ▲|LLY1,192.60+6.73 (+0.57%) ▲|LMT581.87+13.28 (+2.33%) ▲|LOW206.37+4.45 (+2.20%) ▲|LRCX308.15-11.63 (-3.64%) ▼|MA535.59+5.30 (+1.00%) ▲|MCD264.80+2.00 (+0.76%) ▲|MDLZ60.43+0.38 (+0.63%) ▲|MDT83.17+1.16 (+1.41%) ▲|META601.64-4.46 (-0.74%) ▼|MMM170.74+1.15 (+0.68%) ▲|MO73.02+0.94 (+1.30%) ▲|MRK131.06+0.58 (+0.44%) ▲|MS214.83-0.35 (-0.16%) ▼|MSFT384.21+2.63 (+0.69%) ▲|MU921.13-69.08 (-6.98%) ▼|NEE89.17-0.63 (-0.70%) ▼|NFLX70.21+1.32 (+1.91%) ▲|NKE41.82+0.83 (+2.01%) ▲|NOW98.04+6.10 (+6.63%) ▲|NVDA208.57-0.19 (-0.09%) ▼|ORCL116.98-3.07 (-2.55%) ▼|PEP136.67+1.72 (+1.27%) ▲|PFE24.57-0.02 (-0.06%) ▼|PG146.79+0.91 (+0.62%) ▲|PLTR123.90+0.53 (+0.43%) ▲|PM194.43+3.31 (+1.73%) ▲|QCOM167.52-3.59 (-2.10%) ▼|RTX212.90+3.74 (+1.79%) ▲|SBUX103.83+0.62 (+0.60%) ▲|SCHW101.44-0.17 (-0.17%) ▼|SO97.12+0.52 (+0.54%) ▲|SPG228.87+3.67 (+1.63%) ▲|T23.97+1.01 (+4.39%) ▲|TMO562.88-9.44 (-1.65%) ▼|TMUS180.36+9.94 (+5.83%) ▲|TSLA308.00-11.69 (-3.66%) ▼|TXN280.99-4.01 (-1.41%) ▼|UBER69.00+0.09 (+0.13%) ▲|UNH419.92-3.64 (-0.86%) ▼|UNP307.54+3.21 (+1.05%) ▲|UPS114.86+0.76 (+0.67%) ▲|USB63.79+0.46 (+0.73%) ▲|V353.97+2.37 (+0.67%) ▲|VZ45.73+1.91 (+4.35%) ▲|WFC86.45+0.26 (+0.30%) ▲|WMT109.31+0.91 (+0.84%) ▲|XOM156.97+0.08 (+0.05%) ▲|
27.6 C
New York
Friday, July 24, 2026

Tag: hair

newssourceFORcompanyinformationcontent1releasesmarket

Health and Wellness Market Size to Hit $12.9 Trillion by 2031 Growing at a CAGR of 10.9%: Allied Market Research

Prevention and Curing Conditions On The Rise, Strong Demand for Beauty & Personal Care Products, Booming Wellness Tourism and Digital Health Nowadays to Accelerate the Growth of...

dsm-firmenich unveils SENSORIUM™ Seoul: Exploring Fragrance Creation & Ingredients for K-Beauty Futures

KAISERAUGST, Switzerland and MAASTRICHT, Netherlands, June 18, 2026 /PRNewswire/ -- dsm-firmenich, innovators in nutrition, health, and beauty, announces the latest edition of SENSORIUM™, its flagship sensory...

Dreame Technology Unveils High-Performance L50s Pro Ultra and L50 Ultra CE Robotic Vacuum Cleaners in India, Setting New Benchmarks in Suction Performance

Starting 16th June, L50s Pro Ultra and L50 Ultra CE will be available on Amazon India, Dreame Technology India website, Croma, and select retail...

Two Malagasy brothers make history: A testament to family, resilience, and African ambition

They faced everything Everest could throw at them: bone-deep cold, unstable ice in the notorious Khumbu Icefall, and the shadow of tragedy that hung...

Global Times: From Beijing to Athens, touching the warmth of civilizations

BEIJING, June 16, 2026 /PRNewswire/ -- Reading the news about the just concluded Second World Conference of Classics in Athens reminds me of my...

Two Malagasy brothers make history: A testament to family, resilience, and African ambition

They faced everything Everest could throw at them: bone-deep cold, unstable ice in the notorious Khumbu Icefall, and the shadow of tragedy that hung...

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

HAMPTON, N.J., June 14, 2026 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) today presented positive results from the Phase 1 healthy participant study of CDX-622, a novel, bispecific antibody that targets soluble SCF and TSLP, at the European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Istanbul, Türkiye. Data demonstrated that CDX-622 induced rapid, durable, dose-dependent reductions in serum tryptase, indicative of mast cell depletion, and was well-tolerated at all dose levels. Building on Celldex’s leadership in mast cell science, the data also demonstrated that neutralizing soluble stem cell factor (SCF) enables the potential for meaningful mast cell inhibition and depletion without impacting other KIT-dependent functions. CDX-622 is currently being studied in a Phase 1b proof of mechanism study in mild to moderate asthma to assess the impact of dual neutralization of SCF and TSLP.

Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity

TÜBINGEN, Germany, June 12, 2026 /PRNewswire/ -- Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss,...

Promising First-in-Patient Results for ACOU085 (INN: Bimokalner) in Cisplatin-Induced Ototoxicity

TÜBINGEN, Germany, June 12, 2026 /PRNewswire/ -- Acousia Therapeutics GmbH, a clinical-stage biotechnology company pioneering treatments for acute and chronic inner ear hearing loss,...

Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds

Gen Z Is Redefining the Medical Aesthetics Patient Journey, New Guidepoint Qsight Study Finds

Making the Invisible Visible: Microscope Breakthrough Will Open Unprecedented View into Our Cells

Biohub and UC Berkeley show that the laser phase plate, a revolutionary device with a laser 100 million times brighter than the Sun, dramatically...

ZINZINO AB (PUBL.): Zinzino launches Collagen Boozt Flex as beauty-from-within enters daily routines

New powder formula combines marine collagen, hyaluronic acid, postbiotics and selected nutrients for flexible daily beauty routinesGOTHENBURG, Sweden, June 11, 2026 /PRNewswire/ -- As beauty-from-within...

Cynosure Lutronic’s XERF™, Worldwide Adoption Accelerates, Now 3x Faster

Now among the fastest-scaling monopolar RF devices worldwide, XERF™ has more than tripled its pace of adoption in recent months with Asia-Pacific and North...

From Grooming to Goodwill: Wahl® Benevolent Beards Tour Coming to NASCAR San Diego Weekend

For every FREE beard trim, men's grooming leader Wahl® will donate $100 to veterans' charity(see the mobile barbershop in action from last year)STERLING, Ill.,...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsHair

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers